T. Kroell

发表

Various 'dendritic cell antigens' are already expressed on uncultured blasts in acute myeloid leukemia and myelodysplastic syndromes.

H. Salih, A. Kremser, H. Kolb, 2011, Immunotherapy.

Expression profiles of HMGB1 on B-CLL related leukocytes contribute to prediction of relapse.

O. Stoetzer, H. Salih, T. Guenther, 2020, Immunobiology.

In Vitro Generated Dendritic Cells of Leukemic Origin Predict Response to Allogeneic Stem Cell Transplantation in Patients With AML and MDS

A. Kremser, H. Kolb, C. Schmid, 2021, Journal of immunotherapy.

Profiles of Activation, Differentiation–Markers, or &bgr;-Integrins on T Cells Contribute to Predict T Cells’ Antileukemic Responses After Stimulation With Leukemia-derived Dendritic Cells

R. Buhmann, C. Köhne, H. Schmetzer, 2014, Journal of immunotherapy.

Antileukemic T-cell Responses Can Be Predicted by the Composition of Specific Regulatory T-cell Subpopulations

R. Buhmann, C. Köhne, H. Schmetzer, 2013, Journal of immunotherapy.

Expression of 4-1BB and its ligand on blasts correlates with prognosis of patients with AML

L. Kanz, H. Salih, J. Wild, 2016, Journal of Investigative Medicine.

Expression of poliovirus receptor‐related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies

M. Graf, V. Nuessler, H. Schmetzer, 2005, European journal of haematology.

Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts correlations of released chemokines with antileukemic T-cell reactions.

A. Borkhardt, A. Kremser, H. Kolb, 2021, Immunobiology.

WT1, PRAME, and PR3 mRNA Expression in Acute Myeloid Leukemia (AML)

H. Kolb, D. Amberger, H. Schmetzer, 2020, Journal of immunotherapy.

High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML)

M. Graf, H. Schmetzer, T. Kroell, 2005, Annals of Hematology.

Generation of Leukaemia-Derived Dendritic Cells (DCleu) to Improve Anti-Leukaemic Activity in AML: Selection of the Most Efficient Response Modifier Combinations

A. Rank, C. Schmid, D. Amberger, 2022, International journal of molecular sciences.

Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the Disease

A. Borkhardt, A. Kremser, H. Kolb, 2019, Immunological investigations.

Dendritic Cells (DCs) Can Be Successfully Generated From Leukemic Blasts in Individual Patients With AML or MDS: An Evaluation of Different Methods

H. Salih, A. Kremser, S. Kufner, 2010, Journal of immunotherapy.

CD4(+)and CD8(+)T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT.

D. Busch, R. Buhmann, A. Borkhardt, 2014, Immunobiology.

Expression of surface-associated 82kDa-proMMP-9 in primary acute leukemia blast cells inversely correlates with patients' risk.

C. Weber, H. Salih, D. Santovito, 2016, Experimental hematology.

Cytokine Release Patterns in Mixed Lymphocyte Culture (MLC) of T-Cells with Dendritic Cells (DC) Generated from AML Blasts Contribute to Predict anti-Leukaemic T-Cell Reactions and Patients’ Response to Immunotherapy

A. Borkhardt, A. Kremser, H. Kolb, 2015, Cell communication & adhesion.

Expression and prognostic value of FAS receptor/FAS ligand and TrailR1/TrailR2 in acute myeloid leukemia

C. Köhne, C. Schmid, H. Schmetzer, 2011, Hematology.

Leukaemia‐Derived Dendritic Cells Can Be Generated From Blood or Bone Marrow Cells From Patients With Myelodysplasia: A Methodological Approach Under Serum‐Free Culture Conditions

H. Zitzelsberger, H. Kolb, C. Schmid, 2005, Scandinavian journal of immunology.

Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes

H. Zitzelsberger, H. Salih, S. Kufner, 2005, Cancer Immunology, Immunotherapy.

In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping

Arndt Borkhardt, R. Buhmann, A. Borkhardt, 2013, Clinical and Experimental Medicine.

Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential.

R. Reibke, A. Kremser, H. Kolb, 2010, Cellular immunology.

Improved effector function of leukemia-specific T-lymphocyte clones trained with AML-derived dendritic cells.

R. Buhmann, P. Lichtner, A. Borkhardt, 2008, Cancer genomics & proteomics.

Quantification of ex vivo generated dendritic cells (DC) and leukemia-derived DC contributes to estimate the quality of DC, to detect optimal DC-generating methods or to optimize DC-mediated T-cell-activation-procedures ex vivo or in vivo

A. Kremser, H. Kolb, H. Schmetzer, 2007, Leukemia.

Role of Interferon (IFN)&agr; in “Cocktails” for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic Reactions

K. Stein, H. Kolb, C. Schmid, 2019, Journal of immunotherapy.

Paramunity-inducing Factors (PINDs) in dendritic cell (DC) cultures lead to impaired antileukemic functionality of DC-stimulated T-cells.

H. Kolb, H. Schmetzer, T. Kroell, 2018, Cellular immunology.

Combined immunophenotyping and fluorescence in situ hybridization with chromosome-specific DNA probes allows quantification and differentiation of ex vivo generated dendritic cells, leukemia-derived dendritic cells and clonal leukemic cells in patients with acute myeloid leukemia

H. Zitzelsberger, A. Kremser, S. Kufner, 2013, Leukemia & lymphoma.

The Quality and Quantity of Leukemia-derived Dendritic Cells From Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome Are a Predictive Factor for the Lytic Potential of Dendritic Cells-primed Leukemia-Specific T Cells

A. Kremser, H. Kolb, C. Schmid, 2010, Journal of immunotherapy.

Leukemia‐Derived Dendritic Cells can be Generated from Blood or Bone Marrow Cells from Patients with Acute Myeloid Leukaemia: A Methodological Approach under Serum‐Free Culture Conditions

H. Zitzelsberger, H. Kolb, V. Nuessler, 2005, Scandinavian journal of immunology.

Expression of RANK‐L and in part of PD‐1 on blasts in patients with acute myeloid leukemia correlates with prognosis

L. Kanz, H. Salih, J. Wild, 2016, European journal of haematology.

Death Receptor Expression on Blasts in AML Is Associated with Unfavorable Prognosis.

L. Kanz, H. Salih, J. Wild, 2015, Anticancer research.

Various 'dendritic cell antigens' are already expressed on uncultured blasts in acute myeloid leukemia and myelodysplastic syndromes.

H. Salih, A. Kremser, H. Kolb, 2011, Immunotherapy.

CD4(+)and CD8(+)T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT.

D. Busch, R. Buhmann, A. Borkhardt, 2014, Immunobiology.